Madison Memory Study

Participant in the Madison Memory Study

Participant in the Madison Memory Study

Madison Memory Study PDF

The Madison Memory Study Final Report

The Madison Memory Study has been completed.

The Madison Memory Study (MMS) was a three month long double-blinded, placebo-controlled study which assessed the effect of apoaequorin on cognitive function and other quality of life measures in adults over 40 years old with mild memory concerns associated with aging.*

View the Report


The study protocol builds upon the evidence in previous pilot studies which demonstrated apoaequorin improved memory as measured by participant reported outcomes. The technology which MMS uses to measure cognitive changes in participants is a computer based assessment using software developed by CogState Ltd., a global provider of cognitive testing products and services. Participants were tested at baseline and then re-assessed four more times during the three month period.

To learn more about CogState, visit: